person · Reporting owner

Mohan Jitendra

Disclosed activity across 1 company

Tapewire entity: 21501
SEC CIK: 0001998053

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Astera Labs, Inc.ALAB · Entity 1853	Director · Chief Executive Officer	August 17, 2026	August 19, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Astera Labs, Inc.

Report date August 17, 2026 · Filed August 19, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	1,266,665	Ending reported balance After 2026-08-17 transaction · row 18 18 source rows · reconciled sequence Row 1 · 2026-08-17 · Sale · Disposed 578 · Balance 1,356,717 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F2: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $351.7600 to $352.5000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 2 · 2026-08-17 · Sale · Disposed 1,049 · Balance 1,355,668 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F3: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $350.8850 to $351.5000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 3 · 2026-08-17 · Sale · Disposed 1,984 · Balance 1,353,684 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F4: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $348.8000 to $349.7300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 4 · 2026-08-17 · Sale · Disposed 1,057 · Balance 1,352,627 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F5: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $347.6800 to $348.6300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 5 · 2026-08-17 · Sale · Disposed 3,500 · Balance 1,349,127 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F6: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $346.6200 to $347.5600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 6 · 2026-08-17 · Sale · Disposed 2,525 · Balance 1,346,602 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F7: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $345.5900 to $346.5050, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 7 · 2026-08-17 · Sale · Disposed 17,373 · Balance 1,329,229 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F8: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $344.5100 to $345.5000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 8 · 2026-08-17 · Sale · Disposed 3,713 · Balance 1,325,516 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F9: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $343.4100 to $344.4000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 9 · 2026-08-17 · Sale · Disposed 5,449 · Balance 1,320,067 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F10: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $342.4400 to $343.3800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 10 · 2026-08-17 · Sale · Disposed 1,610 · Balance 1,318,457 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F11: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $341.4300 to $342.3800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 11 · 2026-08-17 · Sale · Disposed 2,616 · Balance 1,315,841 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F12: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $340.2200 to $341.2150, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 12 · 2026-08-17 · Sale · Disposed 6,484 · Balance 1,309,357 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F13: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $339.2100 to $340.2000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 13 · 2026-08-17 · Sale · Disposed 7,992 · Balance 1,301,365 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F14: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $338.2000 to $339.1900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 14 · 2026-08-17 · Sale · Disposed 10,438 · Balance 1,290,927 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F15: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $337.2600 to $338.1850, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 15 · 2026-08-17 · Sale · Disposed 2,946 · Balance 1,287,981 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F16: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $336.0450 to $337.0000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 16 · 2026-08-17 · Sale · Disposed 1,782 · Balance 1,286,199 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F17: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $335.2425 to $335.9750, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 17 · 2026-08-17 · Sale · Disposed 6,926 · Balance 1,279,273 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F18: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $333.8100 to $334.8050, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 18 · 2026-08-17 · Sale · Disposed 12,608 · Balance 1,266,665 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F19: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $333.3600 to $333.8000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Common StockSEC Table I · non-derivative	IndirectBy Trust	699,999	Reported balance Holding disclosure · report date 2026-08-17 · row 19 Holding and transaction disclosures are not merged. 1 source row Row 19 · Balance 699,999 F20: These shares are owned directly by an estate planning trust (the "Trust"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Common StockSEC Table I · non-derivative	IndirectBy Living Trust	3,789,232	Reported balance Holding disclosure · report date 2026-08-17 · row 20 Holding and transaction disclosures are not merged. 1 source row Row 20 · Balance 3,789,232 F21: These shares are owned directly by a living trust (the "Living Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Common StockSEC Table I · non-derivative	IndirectBy 2021 Trust 1	700,000	Reported balance Holding disclosure · report date 2026-08-17 · row 21 Holding and transaction disclosures are not merged. 1 source row Row 21 · Balance 700,000 F22: These shares are owned directly by an estate planning trust (the "2021 Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Common StockSEC Table I · non-derivative	IndirectBy 2021 Trust 2	700,000	Reported balance Holding disclosure · report date 2026-08-17 · row 22 Holding and transaction disclosures are not merged. 1 source row Row 22 · Balance 700,000 F23: These shares are owned directly by an estate planning trust (the "2021 Trust 2"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Common StockSEC Table I · non-derivative	IndirectBy 2022 Trust 1	450,001	Reported balance Holding disclosure · report date 2026-08-17 · row 23 Holding and transaction disclosures are not merged. 1 source row Row 23 · Balance 450,001 F24: These shares are owned directly by an estate planning trust (the "2022 Trust 1"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Common StockSEC Table I · non-derivative	IndirectBy 2022 Trust 2	450,001	Reported balance Holding disclosure · report date 2026-08-17 · row 24 Holding and transaction disclosures are not merged. 1 source row Row 24 · Balance 450,001 F25: These shares are owned directly by an estate planning trust (the "2022 Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Filing footnotes · ownership attribution and instrument terms

F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person.

F2: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $351.7600 to $352.5000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $350.8850 to $351.5000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $348.8000 to $349.7300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F5: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $347.6800 to $348.6300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F6: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $346.6200 to $347.5600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F7: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $345.5900 to $346.5050, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F8: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $344.5100 to $345.5000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F9: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $343.4100 to $344.4000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F10: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $342.4400 to $343.3800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F11: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $341.4300 to $342.3800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F12: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $340.2200 to $341.2150, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F13: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $339.2100 to $340.2000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F14: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $338.2000 to $339.1900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F15: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $337.2600 to $338.1850, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F16: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $336.0450 to $337.0000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F17: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $335.2425 to $335.9750, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F18: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $333.8100 to $334.8050, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F19: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $333.3600 to $333.8000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F20: These shares are owned directly by an estate planning trust (the "Trust"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

F21: These shares are owned directly by a living trust (the "Living Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

F22: These shares are owned directly by an estate planning trust (the "2021 Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

F23: These shares are owned directly by an estate planning trust (the "2021 Trust 2"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

F24: These shares are owned directly by an estate planning trust (the "2022 Trust 1"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

F25: These shares are owned directly by an estate planning trust (the "2022 Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
November 17, 2025 Filed Nov 19, 2025 21:19 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	4,421	$146.65	$648,355.57	Disclosure SEC source: 0001998053-25-000005 · wk-form4_1763587164.xml · nonDerivative · entry 1 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,166,456 F1 · kind: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $147.3300 to $146.4200, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
August 20, 2025 Filed Aug 21, 2025 21:12 UTC	Astera Labs, Inc. ALAB · Entity 1853	GiftCommon Stock	150,000	$0.00	$0.00	Disclosure SEC source: 0001736297-25-000119 · wk-form4_1755810769.xml · nonDerivative · entry 1 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By Living Trust Disclosed balance after: 4,130,002 F1 · kind: Represents a bona fide gift of shares to a non-affiliated entity. F2 · ownership.nature: These shares are owned directly by a living trust (the "Living Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
August 18, 2025 Filed Aug 21, 2025 00:28 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	44,551	$183.17	$8,160,397.76	Disclosure SEC source: 0001736297-25-000115 · wk-form4_1755736087.xml · nonDerivative · entry 2 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,170,877 F1 · kind: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $183.4400 to $182.8700, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
August 18, 2025 Filed Aug 21, 2025 00:28 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	46,890	$183.83	$8,619,985.64	Disclosure SEC source: 0001736297-25-000115 · wk-form4_1755736087.xml · nonDerivative · entry 1 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,215,428 F1 · kind: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $184.4400 to $183.4500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
August 07, 2025 Filed Aug 11, 2025 21:13 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	25,420	$170.33	$4,329,732.68	Disclosure SEC source: 0001736297-25-000104 · wk-form4_1754946781.xml · nonDerivative · entry 6 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2022 Trust 2 Disclosed balance after: 450,001 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 3,160 shares sold at prices ranging from $165.3050 to $166.2800, 10,096 shares sold at prices ranging from $166.3000 to $167.2800, 12,689 shares sold at prices ranging from $167.3000 to $168.2900, 20,361 shares sold at prices ranging from $168.3000 to $169.2550, 23,013 shares sold at prices ranging from $169.3000 to $170.2950, 31,359 shares sold at prices ranging from $170.3100 to $171.3000, 28,702 shares sold at prices ranging from $171.3100 to $172.3000, 12,696 shares sold at prices ranging from $172.3300 to $173.2700, 9,562 shares sold at prices ranging from $173.3500 to $174.2200, and 879 shares sold at prices ranging from $174.8600 to $175.0000, inclusive. F3 · price: (Continued from footnote 2) The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2. F9 · ownership.nature: These shares are owned directly by an estate planning trust (the "2022 Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
August 07, 2025 Filed Aug 11, 2025 21:13 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	25,420	$170.33	$4,329,732.68	Disclosure SEC source: 0001736297-25-000104 · wk-form4_1754946781.xml · nonDerivative · entry 5 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2022 Trust 1 Disclosed balance after: 450,001 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 3,160 shares sold at prices ranging from $165.3050 to $166.2800, 10,096 shares sold at prices ranging from $166.3000 to $167.2800, 12,689 shares sold at prices ranging from $167.3000 to $168.2900, 20,361 shares sold at prices ranging from $168.3000 to $169.2550, 23,013 shares sold at prices ranging from $169.3000 to $170.2950, 31,359 shares sold at prices ranging from $170.3100 to $171.3000, 28,702 shares sold at prices ranging from $171.3100 to $172.3000, 12,696 shares sold at prices ranging from $172.3300 to $173.2700, 9,562 shares sold at prices ranging from $173.3500 to $174.2200, and 879 shares sold at prices ranging from $174.8600 to $175.0000, inclusive. F3 · price: (Continued from footnote 2) The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2. F8 · ownership.nature: These shares are owned directly by an estate planning trust (the "2022 Trust 1"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
August 07, 2025 Filed Aug 11, 2025 21:13 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	25,420	$170.33	$4,329,732.68	Disclosure SEC source: 0001736297-25-000104 · wk-form4_1754946781.xml · nonDerivative · entry 4 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2021 Trust 2 Disclosed balance after: 700,000 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 3,160 shares sold at prices ranging from $165.3050 to $166.2800, 10,096 shares sold at prices ranging from $166.3000 to $167.2800, 12,689 shares sold at prices ranging from $167.3000 to $168.2900, 20,361 shares sold at prices ranging from $168.3000 to $169.2550, 23,013 shares sold at prices ranging from $169.3000 to $170.2950, 31,359 shares sold at prices ranging from $170.3100 to $171.3000, 28,702 shares sold at prices ranging from $171.3100 to $172.3000, 12,696 shares sold at prices ranging from $172.3300 to $173.2700, 9,562 shares sold at prices ranging from $173.3500 to $174.2200, and 879 shares sold at prices ranging from $174.8600 to $175.0000, inclusive. F3 · price: (Continued from footnote 2) The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2. F7 · ownership.nature: These shares are owned directly by an estate planning trust (the "2021 Trust 2"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
August 07, 2025 Filed Aug 11, 2025 21:13 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	25,420	$170.33	$4,329,732.68	Disclosure SEC source: 0001736297-25-000104 · wk-form4_1754946781.xml · nonDerivative · entry 3 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2021 Trust 1 Disclosed balance after: 700,000 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 3,160 shares sold at prices ranging from $165.3050 to $166.2800, 10,096 shares sold at prices ranging from $166.3000 to $167.2800, 12,689 shares sold at prices ranging from $167.3000 to $168.2900, 20,361 shares sold at prices ranging from $168.3000 to $169.2550, 23,013 shares sold at prices ranging from $169.3000 to $170.2950, 31,359 shares sold at prices ranging from $170.3100 to $171.3000, 28,702 shares sold at prices ranging from $171.3100 to $172.3000, 12,696 shares sold at prices ranging from $172.3300 to $173.2700, 9,562 shares sold at prices ranging from $173.3500 to $174.2200, and 879 shares sold at prices ranging from $174.8600 to $175.0000, inclusive. F3 · price: (Continued from footnote 2) The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2. F6 · ownership.nature: These shares are owned directly by an estate planning trust (the "2021 Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
August 07, 2025 Filed Aug 11, 2025 21:13 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	25,414	$170.33	$4,328,710.71	Disclosure SEC source: 0001736297-25-000104 · wk-form4_1754946781.xml · nonDerivative · entry 2 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Trust Disclosed balance after: 699,999 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 3,160 shares sold at prices ranging from $165.3050 to $166.2800, 10,096 shares sold at prices ranging from $166.3000 to $167.2800, 12,689 shares sold at prices ranging from $167.3000 to $168.2900, 20,361 shares sold at prices ranging from $168.3000 to $169.2550, 23,013 shares sold at prices ranging from $169.3000 to $170.2950, 31,359 shares sold at prices ranging from $170.3100 to $171.3000, 28,702 shares sold at prices ranging from $171.3100 to $172.3000, 12,696 shares sold at prices ranging from $172.3300 to $173.2700, 9,562 shares sold at prices ranging from $173.3500 to $174.2200, and 879 shares sold at prices ranging from $174.8600 to $175.0000, inclusive. F3 · price: (Continued from footnote 2) The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2. F5 · ownership.nature: These shares are owned directly by an estate planning trust (the "Trust"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
August 07, 2025 Filed Aug 11, 2025 21:13 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	25,423	$170.33	$4,330,243.66	Disclosure SEC source: 0001736297-25-000104 · wk-form4_1754946781.xml · nonDerivative · entry 1 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Living Trust Disclosed balance after: 4,280,002 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 3,160 shares sold at prices ranging from $165.3050 to $166.2800, 10,096 shares sold at prices ranging from $166.3000 to $167.2800, 12,689 shares sold at prices ranging from $167.3000 to $168.2900, 20,361 shares sold at prices ranging from $168.3000 to $169.2550, 23,013 shares sold at prices ranging from $169.3000 to $170.2950, 31,359 shares sold at prices ranging from $170.3100 to $171.3000, 28,702 shares sold at prices ranging from $171.3100 to $172.3000, 12,696 shares sold at prices ranging from $172.3300 to $173.2700, 9,562 shares sold at prices ranging from $173.3500 to $174.2200, and 879 shares sold at prices ranging from $174.8600 to $175.0000, inclusive. F3 · price: (Continued from footnote 2) The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2. F4 · ownership.nature: These shares are owned directly by a living trust (the "Living Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
July 21, 2025 Filed Jul 23, 2025 20:47 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	12,710	$112.72	$1,432,715.69	Disclosure SEC source: 0001736297-25-000086 · wk-form4_1753303673.xml · nonDerivative · entry 6 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2022 Trust 2 Disclosed balance after: 475,421 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 16,071 shares sold at prices ranging from $110.7100 to $111.6550, 31,327 shares sold at prices ranging from $111.7800 to $112.7750, 9,561 shares sold at prices ranging from $112.7900 to $113.7500, 13,172 shares sold at prices ranging from $113.9100 to $114.7200, and 6,127 shares sold at prices ranging from $114.9100 to $115.4400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F8 · ownership.nature: These shares are owned directly by an estate planning trust (the "2022 Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
July 21, 2025 Filed Jul 23, 2025 20:47 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	12,710	$112.72	$1,432,715.69	Disclosure SEC source: 0001736297-25-000086 · wk-form4_1753303673.xml · nonDerivative · entry 5 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2022 Trust 1 Disclosed balance after: 475,421 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 16,071 shares sold at prices ranging from $110.7100 to $111.6550, 31,327 shares sold at prices ranging from $111.7800 to $112.7750, 9,561 shares sold at prices ranging from $112.7900 to $113.7500, 13,172 shares sold at prices ranging from $113.9100 to $114.7200, and 6,127 shares sold at prices ranging from $114.9100 to $115.4400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F7 · ownership.nature: These shares are owned directly by an estate planning trust (the "2022 Trust 1"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
July 21, 2025 Filed Jul 23, 2025 20:47 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	12,710	$112.72	$1,432,715.69	Disclosure SEC source: 0001736297-25-000086 · wk-form4_1753303673.xml · nonDerivative · entry 4 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2021 Trust 2 Disclosed balance after: 725,420 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 16,071 shares sold at prices ranging from $110.7100 to $111.6550, 31,327 shares sold at prices ranging from $111.7800 to $112.7750, 9,561 shares sold at prices ranging from $112.7900 to $113.7500, 13,172 shares sold at prices ranging from $113.9100 to $114.7200, and 6,127 shares sold at prices ranging from $114.9100 to $115.4400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F6 · ownership.nature: These shares are owned directly by an estate planning trust (the "2021 Trust 2"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
July 21, 2025 Filed Jul 23, 2025 20:47 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	12,710	$112.72	$1,432,715.69	Disclosure SEC source: 0001736297-25-000086 · wk-form4_1753303673.xml · nonDerivative · entry 3 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2021 Trust 1 Disclosed balance after: 725,420 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 16,071 shares sold at prices ranging from $110.7100 to $111.6550, 31,327 shares sold at prices ranging from $111.7800 to $112.7750, 9,561 shares sold at prices ranging from $112.7900 to $113.7500, 13,172 shares sold at prices ranging from $113.9100 to $114.7200, and 6,127 shares sold at prices ranging from $114.9100 to $115.4400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F5 · ownership.nature: These shares are owned directly by an estate planning trust (the "2021 Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
July 21, 2025 Filed Jul 23, 2025 20:47 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	12,710	$112.72	$1,432,715.69	Disclosure SEC source: 0001736297-25-000086 · wk-form4_1753303673.xml · nonDerivative · entry 2 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Trust Disclosed balance after: 725,413 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 16,071 shares sold at prices ranging from $110.7100 to $111.6550, 31,327 shares sold at prices ranging from $111.7800 to $112.7750, 9,561 shares sold at prices ranging from $112.7900 to $113.7500, 13,172 shares sold at prices ranging from $113.9100 to $114.7200, and 6,127 shares sold at prices ranging from $114.9100 to $115.4400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F4 · ownership.nature: These shares are owned directly by an estate planning trust (the "Trust"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
July 21, 2025 Filed Jul 23, 2025 20:47 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	12,708	$112.72	$1,432,490.24	Disclosure SEC source: 0001736297-25-000086 · wk-form4_1753303673.xml · nonDerivative · entry 1 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Living Trust Disclosed balance after: 4,305,425 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 16,071 shares sold at prices ranging from $110.7100 to $111.6550, 31,327 shares sold at prices ranging from $111.7800 to $112.7750, 9,561 shares sold at prices ranging from $112.7900 to $113.7500, 13,172 shares sold at prices ranging from $113.9100 to $114.7200, and 6,127 shares sold at prices ranging from $114.9100 to $115.4400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: These shares are owned directly by a living trust (the "Living Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
July 18, 2025 Filed Jul 21, 2025 22:15 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	7,626	$100.25	$764,538.53	Disclosure SEC source: 0001736297-25-000084 · wk-form4_1753136134.xml · nonDerivative · entry 12 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2022 Trust 2 Disclosed balance after: 488,131 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F9 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 45,755 shares sold at prices ranging from $100.0000 to $100.4800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F8 · ownership.nature: These shares are owned directly by an estate planning trust (the "2022 Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
July 18, 2025 Filed Jul 21, 2025 22:15 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	7,626	$100.25	$764,538.53	Disclosure SEC source: 0001736297-25-000084 · wk-form4_1753136134.xml · nonDerivative · entry 11 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2022 Trust 1 Disclosed balance after: 488,131 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F9 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 45,755 shares sold at prices ranging from $100.0000 to $100.4800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F7 · ownership.nature: These shares are owned directly by an estate planning trust (the "2022 Trust 1"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
July 18, 2025 Filed Jul 21, 2025 22:15 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	7,626	$100.25	$764,538.53	Disclosure SEC source: 0001736297-25-000084 · wk-form4_1753136134.xml · nonDerivative · entry 10 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2021 Trust 2 Disclosed balance after: 738,130 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F9 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 45,755 shares sold at prices ranging from $100.0000 to $100.4800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F6 · ownership.nature: These shares are owned directly by an estate planning trust (the "2021 Trust 2"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
July 18, 2025 Filed Jul 21, 2025 22:15 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	7,626	$100.25	$764,538.53	Disclosure SEC source: 0001736297-25-000084 · wk-form4_1753136134.xml · nonDerivative · entry 9 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2021 Trust 1 Disclosed balance after: 738,130 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F9 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 45,755 shares sold at prices ranging from $100.0000 to $100.4800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F5 · ownership.nature: These shares are owned directly by an estate planning trust (the "2021 Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
July 18, 2025 Filed Jul 21, 2025 22:15 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	7,626	$100.25	$764,538.53	Disclosure SEC source: 0001736297-25-000084 · wk-form4_1753136134.xml · nonDerivative · entry 8 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Trust Disclosed balance after: 738,123 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F9 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 45,755 shares sold at prices ranging from $100.0000 to $100.4800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F4 · ownership.nature: These shares are owned directly by an estate planning trust (the "Trust"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
July 18, 2025 Filed Jul 21, 2025 22:15 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	7,625	$100.25	$764,438.28	Disclosure SEC source: 0001736297-25-000084 · wk-form4_1753136134.xml · nonDerivative · entry 7 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Living Trust Disclosed balance after: 4,318,133 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F9 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 45,755 shares sold at prices ranging from $100.0000 to $100.4800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: These shares are owned directly by a living trust (the "Living Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
July 17, 2025 Filed Jul 21, 2025 22:15 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	13,417	$94.37	$1,266,099.23	Disclosure SEC source: 0001736297-25-000084 · wk-form4_1753136134.xml · nonDerivative · entry 6 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2022 Trust 2 Disclosed balance after: 495,757 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 13,554 shares sold at prices ranging from $90.9000 to $91.8900, 23,349 shares sold at prices ranging from $91.900 to $92.8700, 6,301 shares sold at prices ranging from $92.9900 to $93.9800, 1,299 shares sold at prices ranging from $93.9900 to $94.7500, 5,000 shares sold at prices ranging from $95.0800 to $96.0700, 18,247 shares sold at prices ranging from $96.0900 to $97.0800, 9,453 shares sold at prices ranging from $97.0900 to $98.0800, and 3,300 shares sold at prices ranging from $98.0900 to $98.9800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F8 · ownership.nature: These shares are owned directly by an estate planning trust (the "2022 Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
July 17, 2025 Filed Jul 21, 2025 22:15 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	13,417	$94.37	$1,266,099.23	Disclosure SEC source: 0001736297-25-000084 · wk-form4_1753136134.xml · nonDerivative · entry 5 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2022 Trust 1 Disclosed balance after: 495,757 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 13,554 shares sold at prices ranging from $90.9000 to $91.8900, 23,349 shares sold at prices ranging from $91.900 to $92.8700, 6,301 shares sold at prices ranging from $92.9900 to $93.9800, 1,299 shares sold at prices ranging from $93.9900 to $94.7500, 5,000 shares sold at prices ranging from $95.0800 to $96.0700, 18,247 shares sold at prices ranging from $96.0900 to $97.0800, 9,453 shares sold at prices ranging from $97.0900 to $98.0800, and 3,300 shares sold at prices ranging from $98.0900 to $98.9800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F7 · ownership.nature: These shares are owned directly by an estate planning trust (the "2022 Trust 1"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
July 17, 2025 Filed Jul 21, 2025 22:15 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	13,417	$94.37	$1,266,099.23	Disclosure SEC source: 0001736297-25-000084 · wk-form4_1753136134.xml · nonDerivative · entry 4 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2021 Trust 2 Disclosed balance after: 745,756 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 13,554 shares sold at prices ranging from $90.9000 to $91.8900, 23,349 shares sold at prices ranging from $91.900 to $92.8700, 6,301 shares sold at prices ranging from $92.9900 to $93.9800, 1,299 shares sold at prices ranging from $93.9900 to $94.7500, 5,000 shares sold at prices ranging from $95.0800 to $96.0700, 18,247 shares sold at prices ranging from $96.0900 to $97.0800, 9,453 shares sold at prices ranging from $97.0900 to $98.0800, and 3,300 shares sold at prices ranging from $98.0900 to $98.9800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F6 · ownership.nature: These shares are owned directly by an estate planning trust (the "2021 Trust 2"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
July 17, 2025 Filed Jul 21, 2025 22:15 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	13,417	$94.37	$1,266,099.23	Disclosure SEC source: 0001736297-25-000084 · wk-form4_1753136134.xml · nonDerivative · entry 3 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2021 Trust 1 Disclosed balance after: 745,756 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 13,554 shares sold at prices ranging from $90.9000 to $91.8900, 23,349 shares sold at prices ranging from $91.900 to $92.8700, 6,301 shares sold at prices ranging from $92.9900 to $93.9800, 1,299 shares sold at prices ranging from $93.9900 to $94.7500, 5,000 shares sold at prices ranging from $95.0800 to $96.0700, 18,247 shares sold at prices ranging from $96.0900 to $97.0800, 9,453 shares sold at prices ranging from $97.0900 to $98.0800, and 3,300 shares sold at prices ranging from $98.0900 to $98.9800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F5 · ownership.nature: These shares are owned directly by an estate planning trust (the "2021 Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
July 17, 2025 Filed Jul 21, 2025 22:15 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	13,417	$94.37	$1,266,099.23	Disclosure SEC source: 0001736297-25-000084 · wk-form4_1753136134.xml · nonDerivative · entry 2 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Trust Disclosed balance after: 745,749 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 13,554 shares sold at prices ranging from $90.9000 to $91.8900, 23,349 shares sold at prices ranging from $91.900 to $92.8700, 6,301 shares sold at prices ranging from $92.9900 to $93.9800, 1,299 shares sold at prices ranging from $93.9900 to $94.7500, 5,000 shares sold at prices ranging from $95.0800 to $96.0700, 18,247 shares sold at prices ranging from $96.0900 to $97.0800, 9,453 shares sold at prices ranging from $97.0900 to $98.0800, and 3,300 shares sold at prices ranging from $98.0900 to $98.9800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F4 · ownership.nature: These shares are owned directly by an estate planning trust (the "Trust"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
July 17, 2025 Filed Jul 21, 2025 22:15 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	13,418	$94.37	$1,266,193.60	Disclosure SEC source: 0001736297-25-000084 · wk-form4_1753136134.xml · nonDerivative · entry 1 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Living Trust Disclosed balance after: 4,325,758 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 13,554 shares sold at prices ranging from $90.9000 to $91.8900, 23,349 shares sold at prices ranging from $91.900 to $92.8700, 6,301 shares sold at prices ranging from $92.9900 to $93.9800, 1,299 shares sold at prices ranging from $93.9900 to $94.7500, 5,000 shares sold at prices ranging from $95.0800 to $96.0700, 18,247 shares sold at prices ranging from $96.0900 to $97.0800, 9,453 shares sold at prices ranging from $97.0900 to $98.0800, and 3,300 shares sold at prices ranging from $98.0900 to $98.9800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: These shares are owned directly by a living trust (the "Living Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
July 10, 2025 Filed Jul 11, 2025 22:56 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	1,880	$102.46	$192,626.12	Disclosure SEC source: 0001736297-25-000078 · wk-form4_1752274593.xml · nonDerivative · entry 12 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2022 Trust 2 Disclosed balance after: 509,174 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F9 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 10,909 shares sold at prices ranging from $102.0400 to $103.0350, inclusive, and 373 shares sold at a price of $103.1350. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F8 · ownership.nature: These shares are owned directly by an estate planning trust (the "2022 Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
July 10, 2025 Filed Jul 11, 2025 22:56 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	1,880	$102.46	$192,626.12	Disclosure SEC source: 0001736297-25-000078 · wk-form4_1752274593.xml · nonDerivative · entry 11 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2022 Trust 1 Disclosed balance after: 509,174 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F9 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 10,909 shares sold at prices ranging from $102.0400 to $103.0350, inclusive, and 373 shares sold at a price of $103.1350. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F7 · ownership.nature: These shares are owned directly by an estate planning trust (the "2022 Trust 1"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
July 10, 2025 Filed Jul 11, 2025 22:56 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	1,880	$102.46	$192,626.12	Disclosure SEC source: 0001736297-25-000078 · wk-form4_1752274593.xml · nonDerivative · entry 10 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2021 Trust 2 Disclosed balance after: 759,173 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F9 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 10,909 shares sold at prices ranging from $102.0400 to $103.0350, inclusive, and 373 shares sold at a price of $103.1350. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F6 · ownership.nature: These shares are owned directly by an estate planning trust (the "2021 Trust 2"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
July 10, 2025 Filed Jul 11, 2025 22:56 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	1,880	$102.46	$192,626.12	Disclosure SEC source: 0001736297-25-000078 · wk-form4_1752274593.xml · nonDerivative · entry 9 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2021 Trust 1 Disclosed balance after: 759,173 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F9 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 10,909 shares sold at prices ranging from $102.0400 to $103.0350, inclusive, and 373 shares sold at a price of $103.1350. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F5 · ownership.nature: These shares are owned directly by an estate planning trust (the "2021 Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
July 10, 2025 Filed Jul 11, 2025 22:56 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	1,880	$102.46	$192,626.12	Disclosure SEC source: 0001736297-25-000078 · wk-form4_1752274593.xml · nonDerivative · entry 8 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Trust Disclosed balance after: 759,166 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F9 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 10,909 shares sold at prices ranging from $102.0400 to $103.0350, inclusive, and 373 shares sold at a price of $103.1350. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F4 · ownership.nature: These shares are owned directly by an estate planning trust (the "Trust"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
July 10, 2025 Filed Jul 11, 2025 22:56 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	1,882	$102.46	$192,831.04	Disclosure SEC source: 0001736297-25-000078 · wk-form4_1752274593.xml · nonDerivative · entry 7 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Living Trust Disclosed balance after: 4,339,176 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F9 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 10,909 shares sold at prices ranging from $102.0400 to $103.0350, inclusive, and 373 shares sold at a price of $103.1350. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: These shares are owned directly by a living trust (the "Living Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
July 09, 2025 Filed Jul 11, 2025 22:56 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	1,164	$100.01	$116,410.71	Disclosure SEC source: 0001736297-25-000078 · wk-form4_1752274593.xml · nonDerivative · entry 6 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2022 Trust 2 Disclosed balance after: 511,054 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 6,982 shares sold at prices ranging from $100.0000 to $100.0800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F8 · ownership.nature: These shares are owned directly by an estate planning trust (the "2022 Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
July 09, 2025 Filed Jul 11, 2025 22:56 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	1,164	$100.01	$116,410.71	Disclosure SEC source: 0001736297-25-000078 · wk-form4_1752274593.xml · nonDerivative · entry 5 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2022 Trust 1 Disclosed balance after: 511,054 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 6,982 shares sold at prices ranging from $100.0000 to $100.0800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F7 · ownership.nature: These shares are owned directly by an estate planning trust (the "2022 Trust 1"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
July 09, 2025 Filed Jul 11, 2025 22:56 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	1,164	$100.01	$116,410.71	Disclosure SEC source: 0001736297-25-000078 · wk-form4_1752274593.xml · nonDerivative · entry 4 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2021 Trust 2 Disclosed balance after: 761,053 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 6,982 shares sold at prices ranging from $100.0000 to $100.0800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F6 · ownership.nature: These shares are owned directly by an estate planning trust (the "2021 Trust 2"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
July 09, 2025 Filed Jul 11, 2025 22:56 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	1,164	$100.01	$116,410.71	Disclosure SEC source: 0001736297-25-000078 · wk-form4_1752274593.xml · nonDerivative · entry 3 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2021 Trust 1 Disclosed balance after: 761,053 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 6,982 shares sold at prices ranging from $100.0000 to $100.0800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F5 · ownership.nature: These shares are owned directly by an estate planning trust (the "2021 Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
July 09, 2025 Filed Jul 11, 2025 22:56 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	1,164	$100.01	$116,410.71	Disclosure SEC source: 0001736297-25-000078 · wk-form4_1752274593.xml · nonDerivative · entry 2 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Trust Disclosed balance after: 761,046 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 6,982 shares sold at prices ranging from $100.0000 to $100.0800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F4 · ownership.nature: These shares are owned directly by an estate planning trust (the "Trust"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
July 09, 2025 Filed Jul 11, 2025 22:56 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	1,162	$100.01	$116,210.69	Disclosure SEC source: 0001736297-25-000078 · wk-form4_1752274593.xml · nonDerivative · entry 1 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Living Trust Disclosed balance after: 4,341,058 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 6,982 shares sold at prices ranging from $100.0000 to $100.0800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: These shares are owned directly by a living trust (the "Living Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
June 20, 2025 Filed Jun 24, 2025 20:45 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	8,790	$100.86	$886,535.67	Disclosure SEC source: 0001736297-25-000072 · wk-form4_1750797901.xml · nonDerivative · entry 6 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2022 Trust 2 Disclosed balance after: 512,218 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 27,056 shares sold at prices ranging from $100.0000 to $100.9900, and 25,687 shares sold at prices ranging from $100.9950 to $101.7300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F8 · ownership.nature: These shares are owned directly by an estate planning trust (the "2022 Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
June 20, 2025 Filed Jun 24, 2025 20:45 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	8,790	$100.86	$886,535.67	Disclosure SEC source: 0001736297-25-000072 · wk-form4_1750797901.xml · nonDerivative · entry 5 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2022 Trust 1 Disclosed balance after: 512,218 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 27,056 shares sold at prices ranging from $100.0000 to $100.9900, and 25,687 shares sold at prices ranging from $100.9950 to $101.7300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F7 · ownership.nature: These shares are owned directly by an estate planning trust (the "2022 Trust 1"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
June 20, 2025 Filed Jun 24, 2025 20:45 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	8,790	$100.86	$886,535.67	Disclosure SEC source: 0001736297-25-000072 · wk-form4_1750797901.xml · nonDerivative · entry 4 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2021 Trust 2 Disclosed balance after: 762,217 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 27,056 shares sold at prices ranging from $100.0000 to $100.9900, and 25,687 shares sold at prices ranging from $100.9950 to $101.7300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F6 · ownership.nature: These shares are owned directly by an estate planning trust (the "2021 Trust 2"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
June 20, 2025 Filed Jun 24, 2025 20:45 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	8,790	$100.86	$886,535.67	Disclosure SEC source: 0001736297-25-000072 · wk-form4_1750797901.xml · nonDerivative · entry 3 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2021 Trust 1 Disclosed balance after: 762,217 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 27,056 shares sold at prices ranging from $100.0000 to $100.9900, and 25,687 shares sold at prices ranging from $100.9950 to $101.7300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F5 · ownership.nature: These shares are owned directly by an estate planning trust (the "2021 Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
June 20, 2025 Filed Jun 24, 2025 20:45 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	8,793	$100.86	$886,838.24	Disclosure SEC source: 0001736297-25-000072 · wk-form4_1750797901.xml · nonDerivative · entry 2 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Trust Disclosed balance after: 762,210 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 27,056 shares sold at prices ranging from $100.0000 to $100.9900, and 25,687 shares sold at prices ranging from $100.9950 to $101.7300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F4 · ownership.nature: These shares are owned directly by an estate planning trust (the "Trust"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
June 20, 2025 Filed Jun 24, 2025 20:45 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	8,790	$100.86	$886,535.67	Disclosure SEC source: 0001736297-25-000072 · wk-form4_1750797901.xml · nonDerivative · entry 1 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Living Trust Disclosed balance after: 4,342,220 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 27,056 shares sold at prices ranging from $100.0000 to $100.9900, and 25,687 shares sold at prices ranging from $100.9950 to $101.7300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: These shares are owned directly by a living trust (the "Living Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
June 17, 2025 Filed Jun 19, 2025 01:15 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	17,751	$94.54	$1,678,209.72	Disclosure SEC source: 0001736297-25-000065 · wk-form4_1750295709.xml · nonDerivative · entry 6 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2022 Trust 2 Disclosed balance after: 521,008 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 15,279 shares sold at prices ranging from $96.7800 to $95.7950, 21,998 shares sold at prices ranging from $95.7750 to $94.7800, 44,589 shares sold at prices ranging from $94.7700 to $93.7800, and 24,644 shares sold at prices ranging from $93.7700 to $93.3600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F8 · ownership.nature: These shares are owned directly by an estate planning trust (the "2022 Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
June 17, 2025 Filed Jun 19, 2025 01:15 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	17,751	$94.54	$1,678,209.72	Disclosure SEC source: 0001736297-25-000065 · wk-form4_1750295709.xml · nonDerivative · entry 5 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2022 Trust 1 Disclosed balance after: 521,008 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 15,279 shares sold at prices ranging from $96.7800 to $95.7950, 21,998 shares sold at prices ranging from $95.7750 to $94.7800, 44,589 shares sold at prices ranging from $94.7700 to $93.7800, and 24,644 shares sold at prices ranging from $93.7700 to $93.3600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F7 · ownership.nature: These shares are owned directly by an estate planning trust (the "2022 Trust 1"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
June 17, 2025 Filed Jun 19, 2025 01:15 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	17,752	$94.54	$1,678,304.26	Disclosure SEC source: 0001736297-25-000065 · wk-form4_1750295709.xml · nonDerivative · entry 4 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2021 Trust 2 Disclosed balance after: 771,007 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 15,279 shares sold at prices ranging from $96.7800 to $95.7950, 21,998 shares sold at prices ranging from $95.7750 to $94.7800, 44,589 shares sold at prices ranging from $94.7700 to $93.7800, and 24,644 shares sold at prices ranging from $93.7700 to $93.3600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F6 · ownership.nature: These shares are owned directly by an estate planning trust (the "2021 Trust 2"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
June 17, 2025 Filed Jun 19, 2025 01:15 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	17,752	$94.54	$1,678,304.26	Disclosure SEC source: 0001736297-25-000065 · wk-form4_1750295709.xml · nonDerivative · entry 3 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2021 Trust 1 Disclosed balance after: 771,007 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 15,279 shares sold at prices ranging from $96.7800 to $95.7950, 21,998 shares sold at prices ranging from $95.7750 to $94.7800, 44,589 shares sold at prices ranging from $94.7700 to $93.7800, and 24,644 shares sold at prices ranging from $93.7700 to $93.3600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F5 · ownership.nature: These shares are owned directly by an estate planning trust (the "2021 Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.